A5013278791- Acute Ischemic Stroke Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Vitamin K Research Studies
- Multiple Sclerosis Research Studies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Stroke Rehabilitation and Recovery
- Venous Thromboembolism Diagnosis and Management
- Sleep and related disorders
- Renin-Angiotensin System Studies
- Nigella sativa pharmacological applications
- Diabetic Foot Ulcer Assessment and Management
- Atrial Fibrillation Management and Outcomes
- Circadian rhythm and melatonin
University of Udine
2023-2025
Introduction: Mechanical thrombectomy (MT) is the standard treatment for acute ischemic stroke (AIS) due to anterior large vessel occlusion (LVO). Despite successful recanalization, some patients remain disabled after 3 months. Mechanisms that can cause futile recanalization (FR) are still largely unknown. We investigated if stress hyperglycemia might be associated with FR. Patients and methods: This a retrospective analysis of consecutive treated in four participating centers between...
Abstract Some patients with large vessel occlusion (LVO) achieve insufficient clinical improvement (futile recanalization, FR) after intravenous thrombolysis (IVT) during inter-hospital transfer for thrombectomy, while others show good outcomes (effective ER). This study assessed FR and ER rates among treated IVT at non-thrombectomy primary stroke centers (PSCs) aimed to identify predictors of FR. We analyzed data from two PSC registries (2016–2022). Inclusion criteria: treatment, anterior...
Patients with multiple sclerosis (MS) frequently report sleep complaints. The ketogenic diet (KD) is safe and tolerable in MS patients. Our aim was: 1) to investigate the effects of KD on complaints patients affected by relapsing-remitting 2) verify if changes can positively impact psychological status quality life (QoL) these
Introduction The drug most frequently used for thrombolysis in cases of acute ischemic stroke (AIS) is alteplase. However, there moderate-to-high-quality evidence that tenecteplase has similar or higher efficacy and safety. With improved pharmacokinetic properties over alteplase, could be a significant advantage treating AIS.